8 Related Guidance

8 Related Guidance

8.1 The Institute issued guidance in September 2001 on the use of taxanes for the treatment of breast cancer:

  • National Institute for Clinical Excellence (2001) Guidance on the use of taxanes for the treatment of breast cancer: NICE Technology Appraisal Guidance No. 30. London: National Institute for Clinical Excellence. [Replaced by NICE clinical guideline 81]